| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Melissa Thomas, Ellen Berni, Sara Jenkins-Jones, Sarah Wensley, Chris D Poole, Craig J Currie, Jack Brownrigg, John Ayuk, D Aled Ree. Insulin-like growth factor-1, growth hormone and disease outcomes in acromegaly: A population study. Clinical endocrinology. vol 95. issue 1. 2021-10-27. PMID:33749903. |
a lack of consensus remains about the relative importance of insulin-like growth factor-1 (igf-1) and growth hormone (gh) in predicting adverse outcomes in patients with acromegaly. |
2021-10-27 |
2023-08-13 |
Not clear |
| Karina Zanlorenzi Basso Manosso, Carolina Labigalini Sampaio, Leandro Kasuki, Ximene Antunes, Monica R Gadelha, Cesar Luiz Boguszewsk. GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly: a comparative study between two reference centers for pituitary diseases in Brazil. Endocrine. vol 74. issue 1. 2021-10-25. PMID:34041695. |
gh and igf-i levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly: a comparative study between two reference centers for pituitary diseases in brazil. |
2021-10-25 |
2023-08-13 |
Not clear |
| V Cambria, G Beccuti, N Prencipe, F Penner, V Gasco, F Gatti, M Romanisio, M Caputo, E Ghigo, F Zenga, S Grottol. First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence. Journal of endocrinological investigation. vol 44. issue 11. 2021-10-23. PMID:33837920. |
few studies have evaluated the use of early postoperative growth hormone (gh) levels as a test to predict short- and long-term remission of acromegaly. |
2021-10-23 |
2023-08-13 |
Not clear |
| Lisa Sze, René L Bernays, Cornelia Zwimpfer, Peter Wiesli, Michael Brändle, Christoph Schmi. Impact of Growth Hormone on Cystatin C. Nephron extra. vol 3. issue 1. 2021-10-21. PMID:24348508. |
in this study, we examined the effect of growth hormone (gh) on cysc in patients with acromegaly undergoing transsphenoidal surgery. |
2021-10-21 |
2023-08-12 |
Not clear |
| Júnia R O L Schweizer, Katharina Schilbach, Michael Haenelt, Alexandre V Giannetti, Mariana F Bizzi, Beatriz S Soares, Eduardo Paulino, Jochen Schopohl, Sylvère Störmann, Antônio Ribeiro-Oliveira, Martin Bidlingmaie. Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity. The Journal of clinical endocrinology and metabolism. vol 106. issue 8. 2021-10-18. PMID:33864468. |
soluble alpha klotho (sαkl) has been linked to growth hormone (gh) action, but systematic evaluation and comparisons with traditional biomarkers in acromegaly are lacking. |
2021-10-18 |
2023-08-13 |
Not clear |
| Abdalla Elbial. Ageing genetic signature of hypersomatotropism. Open biology. vol 11. issue 4. 2021-10-15. PMID:33849304. |
acromegaly is a pathological condition that is caused by over-secretion of growth hormone (gh) and develops primarily from a pituitary adenoma. |
2021-10-15 |
2023-08-13 |
zebrafish |
| Abdalla Elbial. Ageing genetic signature of hypersomatotropism. Open biology. vol 11. issue 4. 2021-10-15. PMID:33849304. |
studying the effect of excess gh on the cellular level could help to understand the underlying causes of acromegaly health complications and comorbidities. |
2021-10-15 |
2023-08-13 |
zebrafish |
| Abdalla Elbial. Ageing genetic signature of hypersomatotropism. Open biology. vol 11. issue 4. 2021-10-15. PMID:33849304. |
in our previous publications, we have shown that excess gh reduces body side population (sp) stem cells and induces signs of premature ageing in an acromegaly zebrafish model. |
2021-10-15 |
2023-08-13 |
zebrafish |
| Florica Sandru, Adelina Popa, Dan Nicolae Paduraru, Alexandru Filipescu, Mara Carsote, Adina Ghemigia. Skin anomalies in acromegalic patients (Review of the practical aspects). Experimental and therapeutic medicine. vol 22. issue 5. 2021-10-12. PMID:34630684. |
acromegaly is a hormonal disorder which occurs as the result of growth hormone (gh) and insulin growth factor 1 (igf-1) over-secretion; both hormones are related to skin anomalies. |
2021-10-12 |
2023-08-13 |
human |
| Elena V Varlamov, Matthew D Wood, Joao Prola Netto, Jaclyn Thiessen, Jung Kim, Dawn Shao Ting Lim, Christine G Yedinak, Swechya Banskota, Justin S Cetas, Maria Fleseri. Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly. Pituitary. vol 23. issue 6. 2021-10-06. PMID:32870441. |
to investigate demographic, imaging and laboratory characteristics, and treatment outcomes of acromegaly patients who have bihormonal (ba) growth hormone (gh) and prolactin (prl) immunoreactive adenomas compared to patients who have densely granulated gh adenomas (dga) and sparsely granulated gh adenomas (sga). |
2021-10-06 |
2023-08-13 |
Not clear |
| M Araujo-Castro, E Pascual-Corrales, V Martínez-Vaello, G Baonza Saiz, J Quiñones de Silva, A Acitores Cancela, A M García Cano, V Rodríguez Berroca. Predictive model of surgical remission in acromegaly: age, presurgical GH levels and Knosp grade as the best predictors of surgical remission. Journal of endocrinological investigation. vol 44. issue 1. 2021-10-04. PMID:32441006. |
predictive model of surgical remission in acromegaly: age, presurgical gh levels and knosp grade as the best predictors of surgical remission. |
2021-10-04 |
2023-08-13 |
Not clear |
| Yichao Zhang, Meng Wang, Chenxing Ji, Zhengyuan Chen, Hui Yang, Lei Wang, Yifei Yu, Nidan Qiao, Zengyi Ma, Zhao Ye, Xiaoqing Shao, Wenjuan Liu, Yi Wang, Wei Gong, Vladimir Melnikov, Lydia Hu, Eun Jig Lee, Hongying Ye, Yongfei Wang, Yiming Li, Min He, Yao Zhao, Zhaoyun Zhan. Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver. iScience. vol 24. issue 9. 2021-09-30. PMID:34485865. |
rosiglitazone, a synthetic peroxisome proliferator-activated receptor γ (pparγ) ligand, has been reported to reduce growth hormone (gh) and insulin-like growth factor-1 (igf-1) in 10 patients with acromegaly. |
2021-09-30 |
2023-08-13 |
mouse |
| Yichao Zhang, Meng Wang, Chenxing Ji, Zhengyuan Chen, Hui Yang, Lei Wang, Yifei Yu, Nidan Qiao, Zengyi Ma, Zhao Ye, Xiaoqing Shao, Wenjuan Liu, Yi Wang, Wei Gong, Vladimir Melnikov, Lydia Hu, Eun Jig Lee, Hongying Ye, Yongfei Wang, Yiming Li, Min He, Yao Zhao, Zhaoyun Zhan. Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver. iScience. vol 24. issue 9. 2021-09-30. PMID:34485865. |
rosiglitazone as monotherapy effectively decreases gh and igf-1 levels in all nineteen patients with active acromegaly. |
2021-09-30 |
2023-08-13 |
mouse |
| Thalijn L C Wolters, Mihai G Netea, Niels P Riksen, Adrianus R M M Hermus, Romana T Netea-Maie. Acromegaly, inflammation and cardiovascular disease: a review. Reviews in endocrine & metabolic disorders. vol 21. issue 4. 2021-09-27. PMID:32458292. |
acromegaly is characterized by growth hormone (gh) and insulin-like growth factor 1 (igf-1) excess. |
2021-09-27 |
2023-08-13 |
Not clear |
| Claudia Campana, Francesco Cocchiara, Giuliana Corica, Federica Nista, Marica Arvigo, Jessica Amarù, Diego Criminelli Rossi, Gianluigi Zona, Diego Ferone, Federico Gatt. Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment. The Journal of clinical endocrinology and metabolism. vol 106. issue 3. 2021-09-20. PMID:33236108. |
discordant gh and igf-1 results in treated acromegaly: impact of gh cutoffs and mean values assessment. |
2021-09-20 |
2023-08-13 |
Not clear |
| Claudia Campana, Francesco Cocchiara, Giuliana Corica, Federica Nista, Marica Arvigo, Jessica Amarù, Diego Criminelli Rossi, Gianluigi Zona, Diego Ferone, Federico Gatt. Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment. The Journal of clinical endocrinology and metabolism. vol 106. issue 3. 2021-09-20. PMID:33236108. |
discordant growth hormone (gh) and insulin-like growth factor-1 (igf-1) values are frequent in acromegaly. |
2021-09-20 |
2023-08-13 |
Not clear |
| Pinar Akhanli, Sema Hepşen, Bekir Uçan, Hakan Düğer, Hayri Bostan, Muhammed Kizilgül, Muhammed Erkam Sencar, Erman Çaka. The Evaluation of Breast Findings Detected Through Different Visualisation Techniques in Acromegaly Patients- A Retrospective Study. Turkish journal of medical sciences. 2021-09-17. PMID:34530525. |
it is known that the increased growth hormone (gh) and insulin-like growth factor-1 (igf-1) have mitogenic and antiapoptotic properties in breast cells in acromegaly. |
2021-09-17 |
2023-08-13 |
Not clear |
| Nina Ionovici, Mara Carsote, Dana Cristina Terzea, Anca Mihaela Predescu, Anne Marie Rauten, Mihaela Popesc. Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. vol 61. issue 2. 2021-09-16. PMID:33544787. |
this is a narrative review of literature introducing somatostatin receptors (sstrs) as part of understanding the somatotroph cells since they are positive in normal cells but also in tumoral cells as seen in somatotropinoma, a growth hormone (gh)-producing neoplasia, which causes acromegaly. |
2021-09-16 |
2023-08-13 |
human |
| Joanna Szydełko, Magdalena Szydełko-Gorzkowicz, Beata Matyjaszek-Matusze. Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte Ratios, and Systemic Immune-Inflammation Index as Potential Biomarkers of Chronic Inflammation in Patients with Newly Diagnosed Acromegaly: A Single-Centre Study. Journal of clinical medicine. vol 10. issue 17. 2021-09-14. PMID:34501445. |
acromegaly is a rare disease caused by overproduction of growth hormone (gh) by a pituitary adenoma, and consequently increased insulin-like growth factor 1 (igf-1) concentration. |
2021-09-14 |
2023-08-13 |
Not clear |
| Cecilia Catellani, Gloria Ravegnini, Chiara Sartori, Sabrina Angelini, Maria E Stree. GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer. Frontiers in endocrinology. vol 12. 2021-09-07. PMID:34484116. |
pituitary adenomas are increasingly common intracranial tumors and somatotroph adenomas determine supra-physiological gh secretion and cause acromegaly. |
2021-09-07 |
2023-08-13 |
Not clear |